Vontobel Holding Ltd. Guardant Health, Inc. Transaction History

Vontobel Holding Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 03, 2024	BUY	$22.92 - $33.76 $207,678 - $305,899	9,061 New	9,061 $212,000
Q1 2023 Apr 12, 2023	SELL	$22.92 - $33.76 $12,628 - $18,601	-551 Reduced 5.73%	9,061 $212,000
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $58,588 - $137,673	-2,303 Reduced 19.33%	9,612 $261,000
Q3 2022 Nov 04, 2022	SELL	$43.66 - $61.0 $41,389 - $57,828	-948 Reduced 7.37%	11,915 $641,000
Q2 2022 Jul 27, 2022	SELL	$28.82 - $77.35 $106,201 - $285,034	-3,685 Reduced 22.27%	12,863 $541,000
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $134,955 - $281,070	2,797 Added 20.34%	16,548 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $190,016 - $257,961	2,142 Added 18.45%	13,751 $1.38 Million
Q3 2021 Oct 29, 2021	BUY	$98.77 - $132.17 $98,473 - $131,773	997 Added 9.4%	11,609 $1.45 Million
Q2 2021 Aug 06, 2021	BUY	$109.77 - $165.68 $558,839 - $843,476	5,091 Added 92.21%	10,612 $1.36 Million
Q1 2021 May 11, 2021	BUY	$127.04 - $179.1 $4,192 - $5,910	33 Added 0.6%	5,521 $843,000
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $548,580 - $745,983	5,488 New	5,488 $889,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.